The Test of Memory Malingering (TOMM): normative data from cognitively intact, cognitively impaired, and elderly patients with dementia
|
|
- Imogen Sullivan
- 6 years ago
- Views:
Transcription
1 Archives of Clinical Neuropsychology 19 (2004) The Test of Memory Malingering (TOMM): normative data from cognitively intact, cognitively impaired, and elderly patients with dementia Gordon Teichner, Mark T. Wagner Department of Neurology, Medical University of South Carolina, 222 W. Coleman Blvd., Mt. Pleasant, SC 29464, USA Accepted 22 May 2003 Abstract This research adds to the psychometric validation of the Test of Memory Malingering (TOMM) by providing data for samples of elderly patients who are cognitively intact, cognitively impaired (non-dementia), and with dementia. Subjects were 78 individuals referred for evaluation of memory complaints. Significant group differences emerged between the dementia group and the two other groups (normals and cognitively impaired), although the latter two did not differ from each other. One hundred percent of normals and 92.7% of the cognitively impaired group made fewer than five errors (the suggested cut-off) on Trial 2 or the Retention trial of the TOMM, yielding an overall correct classification rate of 94.7%. However, the rate of misclassification for persons with dementia was high whether using a cut-point score of five, eight, or ten errors. This investigation extends the validity and clinical utility of this instrument. Results suggest that the TOMM is an useful index for detecting the malingering of memory deficits, even in patients with cognitive impairment, but only when dementia can be ruled out National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved. Keywords: Malingering; Test validity; Measurement; Dementia; Geriatrics; Test of Memory Malingering The detection of malingering or purposeful exaggeration of symptoms is a complex and critical issue that neuropsychologists may encounter, especially in the medicolegal arena. The Diagnostic and Statistics Manual of Mental Disorders Fourth Edition (1994) defines malingering as, Corresponding author. Tel.: ; fax: address: teichneg@musc.edu (G. Teichner) /$ see front matter 2003 National Academy of Neuropsychology. doi: /s (03)
2 456 G. Teichner, M.T. Wagner / Archives of Clinical Neuropsychology 19 (2004) the intentional production of false or grossly exaggerated physical or psychological symptoms, motivated by external incentives such as avoiding military duty, avoiding work, obtaining financial compensation, evading criminal prosecution, or obtaining drugs. (p. 683) Patients who malinger symptoms are motivated by an external incentive. Common incentives include receiving compensation, avoidance of responsibility, threat of punishment, or retaliation. The possibility of symptom exaggeration or feigning should be objectively examined when: (1) the patient presents in a medicolegal context such as litigation or application for disability; (2) identifiable incentives for exaggeration are present; (3) symptoms do not make medical, neuropsychological, or psychological sense; (4) the claimed disability is in excess of objective findings; (5) a lack of cooperation during the evaluation occurs; (6) inconsistencies between complaints and behavior are observed; or, (7) contradictions between self-report and medical records are present. The issue of detecting exaggerated or deliberately faked cognitive impairment is paramount in many clinical, medicolegal, and forensic cases. Assessment results often determine whether a patient receives financial or personal gains, or determines the initial course of treatment. Recent times have seen the increased involvement of neuropsychologists in various forensic contexts. This has incited considerable discussion regarding the detection of malingering in the research literature (e.g., Franzen & Iverson, 1997; van Gorp et al., 1999; Gouvier, Hayes, & Smiroldo, 1998; Hartlage, 1998; Heubrock & Petermann, 1998; Pankratz & Binder, 1997; Slick, Sherman, & Iverson, 1999; Williams, 1998), while a plethora of formulas and actuarial effort assessment tools have been developed and put to the empirical method (e.g., Donders, 1999; Frederick & Crosby, 2000; Golden & Grier, 1998; Green, Iverson, & Allen, 1999; Grote et al., 2000; Iverson, Slick, & Franzen, 2000; McKinzey, Podd, Krehbiel, Mensch, & Trombka, 1997; McKinzey & Russell, 1997; Meyers & Volbrecht, 1999; Mittenberg, Rotholc, Russell, & Heilbronner, 1996; Reitan & Wolfson, 1998; Scott-Killgore & DellaPietra, 2000). One such actuarial assessment of testing effort is the Test of Memory Malingering (TOMM), originated by Tombaugh (1996). The TOMM is a 50-item recognition test designed for adults to discriminate between true memory-impaired patients and malingerers. The initial validation studies of the TOMM (see Rees, Tombaugh, Gansler, & Moczynski, 1998; Tombaugh, 1996, 1997) indicate that this instrument is a useful test for detecting exaggerated or malingered memory impairment. Using a criterion cut-off score of 45 on Trial 2 (i.e., 90% correct responding), Tombaugh s investigations (see Rees et al., 1998; Tombaugh, 1996, 1997) revealed correct classification of 95% of all non-demented patients as not malingering. A specificity of 91% was achieved when considering all patients, including those with dementia. Specificity was 100% in an experiment of controls versus simulated malingerers when the same cut-point strategy was employed. In a separate investigation, Tombaugh assessed the performance of patient controls, cognitively intact controls, and litigating versus non-litigating TBI patients on the TOMM. Results indicated that the litigating TBI group scored significantly lower than the other groups, while the non-litigating TBI patients did not differ from controls. Tombaugh s initial validation studies of the TOMM support the validity and clinical utility of this instrument in detecting cognitive malingering. However, our review of the literature revealed no other published studies assessing the psychometric properties of this test or its clinical utility; the only studies published to date appear to be authored by the test originator and
3 G. Teichner, M.T. Wagner / Archives of Clinical Neuropsychology 19 (2004) one of his students (Rees et al., 1998). Independent examination of the psychometric properties of actuarial assessment tools, across the age span and with varying clinical groups, is an assertion commonly echoed throughout the literature. Independent psychometric evaluation of the TOMM, with a clinical sample, appears warranted given its current state of limited empirical support outside of the author s laboratory. The purpose of the current research was to add to the psychometric validation of the TOMM by providing data for samples of cognitively intact elderly subjects, patients with dementia (primarily Alzheimer s Disease and Vascular Dementia), and mixed cognitive impairment. Of particular interest was the rate of specificity (i.e., correct classification as not malingering) of the TOMM in this population. Normative and clinical data in older adults will extend the clinical utility of this tool. Additionally, data derived from elderly subjects with dementia or neurological impairment will strengthen the practitioner s confidence in the TOMM to assist in evaluating the testing motivation of younger patients presenting with cognitive complaints. 1. Methods 1.1. Subjects Subjects were 78 elderly patients referred for neuropsychological and neurological evaluation to a Neurology outpatient clinic located at a large University Hospital. All subjects were referred for a dementia examination given complaints of memory loss, functional decline, or other change in cognition. Data was collected on a serial basis over a 12-month period of time. Most (93.6%) were Caucasian, while the remaining sample was African American (6.4%). The sample s mean age was 70.5 (S.D. = 8.5) and they were well educated (M = 14.0 years, S.D. = 3.3). A total of 33 males and 45 females comprised the group. The majority were married (67.9%), with others being widowed (19.2%), divorced (6.4%), separated (2.6%), or never married (2.6%). Data pertaining to the marital status of two subjects (2.6%) was missing Procedure Subjects underwent comprehensive neurological, neuropsychological, and nursing evaluations. Standard metabolic panels were obtained as part of the dementia workup on all subjects to assist in ruling out competing etiologies that may account for cognitive change. ApoE genotyping and neuroradiological studies (i.e., MRI, SPECT, or CT) were obtained to aid in diagnostic clarification. Neurological evaluation included a basic neurological exam, physical exam, and laboratory studies as described above. Neuropsychological examination was comprised of obtaining a clinical history, neurobehavioral examination, and administration of a comprehensive neuropsychological battery. 1 The nursing exam objectively assessed Activities 1 The standard neuropsychological battery was comprised of the Wechsler Adult Intelligence Test Third Edition (WAIS-III), Wechsler Memory Scale Revised (WMS-R), CERAD Neuropsychological Battery, Mini-Mental State Examination, Trails B, Draw-a-Clock, Hooper, Geriatric Depression Scale, Sentence Completion, and Revised Memory and Behavior Problems checklist. Additional neuropsychological tests were given in selected cases to gain further diagnostic clarification (e.g., Wisconsin Card Sorting Task, Grooved Pegboard, Personality Assessment Inventory).
4 458 G. Teichner, M.T. Wagner / Archives of Clinical Neuropsychology 19 (2004) of Daily Living and Independent Activities of Daily Living by having the subject perform specific tasks in the clinic. Diagnosis was determined by team consensus (neurologist, neuropsychologist, geriatric nurse) based on data collected. Clinical criteria for dementia minimally met the Diagnostic and Statistical Manual Fourth Edition (1994) guidelines. For Dementia of the Alzheimer s Type, an extended ADRDA-NINDS (McKhann et al., 1984) clinical criteria was adopted. The State of California Alzheimer s Disease Diagnostic and Treatment Centers (ADDTC) Ischemic Vascular Disease criteria were used in the determination of Vascular Dementia (Chui et al., 1992). Mild Cognitive Impairment (MCI), Age-Associate Cognitive Impairment, and Cognitive Disorder Not Otherwise Specified were determined by criteria established by the NIH and/or DSM-IV. Other psychiatric illness was determined via DSM-IV diagnostic criteria. On this basis, subjects were divided into the following categories: Dementia (N = 21); Cognitive Impairment, but not meeting criteria for dementia (N = 36); and Cognitively Intact (N = 21). 2 Subjects comprising each group are described in Table Measures Subjects underwent comprehensive evaluation as described above. Given the specific aims of this research, selected tests were chosen for examination; these instruments are described in the following Test of Memory Malingering (TOMM) Tombaugh (1996) The TOMM is a 50-item recognition test designed for adults to discriminate between true memory-impaired patients and malingerers. Subjects are shown 50 drawings for 3 s each, at 1 s intervals. Immediately thereafter, they are given 50 recognition panels, with each panel containing the target picture and a new picture. This is a forced choice task, and the subject is required to indicate the picture previously viewed. Feedback regarding the correctness of the subject s response is offered. Two learning trials are given, and a retention trial is administered after a 10 min delay. Scores range from 0 to 50 for each trial. Tombaugh (1996, 1997) indicates that five or more errors on Trial 2 or the Retention trial indicates the possibility of malingering Wechsler Adult Intelligence Scale Third Edition (WAIS-III) Wechsler (1997) The WAIS-III is the latest version of the Wechsler Adult Intelligence scale. Its psychometric properties are documented in the manual (Wechsler, 1997). This instrument consists of several subtests measuring different facets of intelligence, and its inclusion was to illustrate the general intellectual functioning of the three groups. The three composite scores Verbal, Performance, and Full Scale Intelligence Quotients were used for this study. 2 As indicated in Table 1, 7 (33.3%) subjects were free of psychiatric or neurological illness, while the other 14 (66.6%) subjects had an identifiable psychiatric diagnosis or neurological condition. This mixed group of worried well, psychiatric, and neurological (cognitively intact) patients is a better representation of individuals who may present to a real outpatient clinic. Thus, we feel they served as a more appropriate normal comparison group.
5 G. Teichner, M.T. Wagner / Archives of Clinical Neuropsychology 19 (2004) Table 1 Diagnoses of the sample by group Dementia (N = 21) Probable Alzheimer s Disease (AD) 13 Vascular Dementia (VD) 3 Mixed AD/VD 2 Cortico Basal Ganglionic Degeneration 1 Tumor 1 Frontotemporal Dementia 1 Cognitive Impairment (N = 36) Cognitive Disorder Not Otherwise Specified (vascular etiology) 14 Age Associated Cognitive Decline 11 Parkinson s Disease 3 Closed Head Injury 2 Progressive Supranuclear Palsy 1 Primary Progressive Aphasia 2 Alcohol Encephalopathy 1 Herpes Encephalopathy 1 Probable Pick s Disease 1 Cognitively Intact (N = 21) Major Depressive Disorder or Dysthymia 9 No diagnosis 7 Closed Head Injury 2 Bipolar Disorder 1 Seizure Disorder 1 Lymes Encephalopathy 1 N Wechsler Memory Scale Third Edition (WMS-III); Orientation Wechsler (1997) The Orientation subtest of the WMS-III assesses orientation to person, biographical information, place, time, location, and knowledge of the current and previous Presidents. Scores range from 0 to 14. This measure was used to obtain a general measure of orientation Mini-Mental State Examination (MMSE) Folstein, Folstein, and McHugh (1975) The MMSE is a popular screen for cognitive impairment. Items assess aspects of orientation, attention, language, visuoconstruction, and immediate and delayed recall. Scores range from 0 to 30. A cut-off score of <24 may be strongly suggestive of dementia (see Petersen et al., 2001 for a review). Its inclusion was to illustrate the differences between the three clinical groups in terms of global cognitive functioning. 2. Results 2.1. Demographic variables Demographic group differences were analyzed by ANOVA or Chi-square as appropriate. The groups significantly differed for age, with subjects in the dementia group being
6 460 G. Teichner, M.T. Wagner / Archives of Clinical Neuropsychology 19 (2004) Table 2 Group differences across demographic and neuropsychological variables Dementia (N = 21) Cognitively Impaired (N = 36) Normal (N = 21) Variable M S.D. M S.D. M S.D. F (2, 74) P AGE 75.3 a b b <.01 EDUC ns TOMM Trial a b b <.001 Trial a b b <.001 Retention trial 39.5 a b b <.001 IQ FSIQ 80.6 a b c <.001 VIQ 86.3 a b b <.01 PIQ 77.6 a b c <.01 MMSE 19.9 a b c <.001 ORIEN 9.4 a b b <.001 Note: Means in the same row that share the same superscript letters do not differ significantly from one another at P<.05; means that do not share subscripts differ at P<.05. EDUC: Education; TOMM: Test of Memory Malingering; IQ: Wechsler Adult Intelligence Scale Third Edition, FSIQ: Full Scale Intelligence Quotient; VIQ: Verbal Intelligence Quotient; PIQ: Performance Intelligence Quotient; MMSE: Mini-Mental State Examination; ORIEN: Orientation subtest from the Wechsler Memory Scale Revised. significantly older than the other two groups (see Table 2). Age was correlated with performance on Trial 2 (r =.40, P<.01) and Retention trial (r =.50, P<.01) of the TOMM. Education was not significantly related to performance on Trial 2 (r =.03) or Retention trial (r =.04). No other significant demographic group differences or correlations with performance on the TOMM were observed TOMM and neuropsychological group differences Age was used as a covariate in all analyses given significant group differences. A series of Multivariate Analysis of Covariance (MANCOVA), with age as a covariate, were performed between the three groups. Three separate MANCOVAs were calculated: TOMM trials 1, 2, retention; IQ FSIQ, VIQ, PIQ; Mental status Orientation, MMSE. Univariate tests were calculated using Wilks Lambda. Post hoc group comparisons were then performed using the Tukey procedure to reduce the possibility of Type II error given multiple comparisons. These results are displayed in Table 2. The MANCOVA for the two learning and retention trials of the TOMM was significant, F(6, 144) = 11.02, P<.001. Univariate analyses and pairwise comparisons indicated that the Cognitively Intact and Cognitively Impaired groups did not differ from each other across TOMM trials, while both groups scored significantly better than the Dementia group. Group differences were observed for intellectual functions, F(6, 144) = 3.15, P<.01, as normals fared better than the Cognitively Impaired group who in turn performed superior to those in
7 G. Teichner, M.T. Wagner / Archives of Clinical Neuropsychology 19 (2004) Table 3 Percent of correct responses on the TOMM Percent of correct responses Trials <40 Dementia Trial Trial Retention trial Other neurological Trial Trial Retention trial Normals Trial Trial Retention trial the Dementia group for FSIQ and PIQ. Verbal intelligence did not differ significantly between the Cognitively Intact and Cognitively Impaired groups, yet both did better than individuals in the Dementia group. Not surprisingly, the groups differed in relation to mental status, F(4, 146) = 14.6, P<.001, as the MMSE distinguished the three groups, while performance on the WMS-R Orientation subtest was similar for normals and cognitively impaired; the Dementia group scored significantly lower as would be expected Classification rates using Trial 2 and Retention trial of the TOMM Table 3 presents data on the percent of correct responses across TOMM trials for the three groups. Table 4 displays the false positive rates using various cut-points on Trial 2 and the Retention trial. All elderly normals (100%), and the majority (91.7%) of cognitively impaired elderly made fewer than five errors on these TOMM trials. Using eight errors as a cut point improved correct classification of the Cognitively Impaired group to 94.4% using either Trial Table 4 False positive (FP) rates for cut-off points of five, eight, and ten errors on the TOMM Normals (N = 21) Retention trial Trial 2 Cognitively Impaired (N = 36) Dementia (N = 21) Retention trial Trial 2 Retention trial Trial 2 Cut point (number of errors) N (%FP) N (%FP) N (%FP) N (%FP) N (%FP) N (%FP)
8 462 G. Teichner, M.T. Wagner / Archives of Clinical Neuropsychology 19 (2004) or the Retention trial. In contrast, the Dementia group performed poorly on both Trial 2 and Retention trial. The same cut-point strategy revealed a very high false positive rate whether cut-points of five, eight, or ten errors were used. Thus, if dementia can be ruled out, this data indicates that a cut-point score of five errors yields a high level of specificity (i.e., 94.7% of all non-demented patients are correctly classified), and slightly improved when a cut-off of eight errors is used (96.5%). If dementia cannot be ruled out, then the specificity of the TOMM in this elderly sample was poor whether using five errors (76.9%), eight errors (82.1%), or ten errors (85.9%) on Trial Discussion This research adds to the psychometric validation of the TOMM by examining its performance in a sample of cognitively intact elderly, dementia patients, and older adults with cognitive impairment who do not meet diagnostic criteria for dementia. Patients were extensively evaluated by means of neurological, neuropsychological, and nursing examinations to assure accurate diagnostic clarification. As expected, groups significantly differed across specific measures of cognition (e.g., intellectual functioning, MMSE) adding to the confidence of the diagnostic decision. Results add to the validity of the TOMM as a viable utility in the assessment of testing motivation. Non-demented individuals (normals and cognitively impaired) performed similarly on the TOMM independent of their cognitive status. Results are analogous to those documented in the test manual (Tombaugh, 1996) albeit the original validation samples were considerably younger. A cut-point score of five or more errors on the second learning or retention trials yielded a high rate of correct classification, again comparable to Tombaugh s initial studies. Cut-points of eight or ten errors did not significantly improve the test s specificity. Persons with dementia performed significantly poorer than the other two groups across all trials of the TOMM. In contrast to the initial validation studies, a cut-point of five or more errors on Trial 2 or the Retention trial yielded an unacceptably high rate of false positives. More conservative cut-offs of eight or ten errors did not significantly improve the correct classification of individuals with dementia as non-malingering. Findings of the current initiative extend the clinical utility and validity of the TOMM across the age span to include elderly patients. Further, these results add to the neuropsychologist s confidence of making a correct decision regarding the possibility of cognitive malingering in younger adults (e.g., when presenting for the evaluation of Traumatic Brain Injury, Mild Head Injury) given the performance of elderly psychiatric and neurological patients in the current sample. Data indicate that the specificity for the TOMM is high when dementia can be ruled out. However, the TOMM appears sensitive to detect the severe cognitive dysfunction associated with dementia, and is not a useful measure of assessing test motivation for persons with such deficits. It is not clear why the Dementia group in our sample performed so poorly on the TOMM as compared to Tombaugh s Dementia group who performed relatively well. In the test manual, Tombaugh (1996) indicates that the four individuals with dementia who scored below 40 on Trial 2 were moderately to severely demented, with MMSE scores of 7, 15, 16, and 19. The
9 G. Teichner, M.T. Wagner / Archives of Clinical Neuropsychology 19 (2004) manual does not go into further detail regarding the remaining sample s MMSE performance. The range of MMSE scores of our sample was 11 28, with 9 (42.9%) scoring below 19. Thus, it is possible that our dementia sample was more impaired, as a group, as compared to Tombaugh s sample, resulting in poorer performance on the TOMM. Another possible explanation for the poorer performance of our Dementia group may lie in the method of diagnostic classification. Tombaugh (1996) states that the diagnostic status of his clinical sample was based on DSM-III-R or DSM-IV criteria. Our diagnostic strategy utilized the ADRDA-NINDS or ADDTC criteria for Probable Dementia of the Alzheimer s Type or Vascular Dementia rather than the more liberal definitions offered by the DSM. This leads us to speculate that Tombaugh s adoption of the this more stringent classification strategy may have led to similar findings. At present, this research appears to be the only independent study adding to the psychometric validity of the TOMM. Normative and clinical data are provided for a sample of elderly outpatients presenting with memory complaints. Intact and cognitively impaired (without dementia) elderly performed near perfect on Trial 2 and the Retention trials, similar to younger adults with and without cognitive impairment (Tombaugh, 1996, 1997). The specificity of detecting malingering or poor testing motivation across the adult age span is strengthened in light of these results. Research with other clinical samples and larger groups will continue to add to the clinical utility and psychometric validation of this promising instrument. References American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders Fourth edition. Washington, DC. Chui, H. C., Victoroff, J. I., Margolin, D., Jagust, W., Shankle, R., & Katzman, R. (1992). Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer s Disease Diagnostic and Treatment Centers. Neurology, 42, Donders, J. (1999). Specificity of a malingering formula for the Wisconsin Card Sorting Test. Journal of Forensic Neuropsychology, 1, Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, Franzen, M. D., & Iverson, G. L. (1997). The detection of biased responding in neuropsychological assessment. In A. M. Horton, D. Wedding, & J. Webster (Eds.), The neuropsychology handbook, Vol. 1: Foundations and assessment(2nd ed., pp ). New York: Springer Publishing Co. Frederick, R. I., & Crosby, R. D. (2000). Development and validation of the Validity Indicator Profile. Law and Human Behavior, 24, Golden, C. J., & Grier, C. A. (1998). Detecting malingering on the Luria Nebraska Neuropsychological Battery. In C. R. Reynolds (Ed.), Detection of malingering during head injury litigation. Critical issues in neuropsychology (pp ). New York: Plenum Press. van Gorp, W. G., Humphrey, L. A., Kalechstein, A., Brumm, V. L., McMullen, W. J., Stoddard, M., & Pachana, N. A. (1999). How well do standard clinical neuropsychological tests identify malingering? A preliminary analysis. Journal of Clinical and Experimental Neuropsychology, 21, Gouvier, W. D., Hayes, J. S., Smiroldo, B. B. (1998). The significance of base rates, test sensitivity, test specificity, and subjects knowledge of symptoms in assessing TBI sequelae and malingering. In C. R. Reynolds (Ed.), Detection of malingering during head injury litigation. Critical issues in neuropsychology (pp ). New York: Plenum Press.
10 464 G. Teichner, M.T. Wagner / Archives of Clinical Neuropsychology 19 (2004) Green, P., Iverson, G. L., & Allen, L. (1999). Detecting malingering in head injury litigation with the Word Memory Test. Brain Injury, 13, Grote, C. L., Kooker, E. K., Garron, D. C., Nyenhuis, D. L., Clifford, A., & Mattingly, M. L. (2000). Performance of compensation seeking and non-compensation seeking samples on the Victoria Symptom Validity Test: Cross-validation and extension of a standardization study. Journal of Clinical and Experimental Neuropsychology, 22, Hartlage, L. C. (1998). Clinical detection of malingering. In C. R. Reynolds (Ed.), Detection of malingering during head injury litigation. Critical issues in neuropsychology (pp ). New York: Plenum Press. Heubrock, D., & Petermann, F. (1998). Neuropsychological assessment of suspected malingering: Research results, evaluation techniques, and further directions of research and application. European Journal of Psychological Assessment, 14, Iverson, G. L., Slick, D. J., & Franzen, M. D. (2000). Evaluation of a WMS-R malingering index in a non-litigating clinical sample. Journal of Clinical and Experimental Neuropsychology, 22, McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlam, E. M. (1984). Clinical diagnosis of Alzheimer s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer s Disease. Neurology, 34, McKinzey, R. K., Podd, M. H., Krehbiel, M. A., Mensch, A., & Trombka, C. (1997). Detection of malingering on the Luria Nebraska Neuropsychological Battery: An initial and cross-validation. Archives of Clinical Neuropsychology, 12, McKinzey, R. K., & Russell, E. W. (1997). Detection of malingering on the Halstead Reitan Battery: A cross-validation. Archives of Clinical Neuropsychology, 12, Meyers, J. E., & Volbrecht, M. (1999). Detection of malingerers using the Rey Complex Figure and Recognition trial. Applied Neuropsychology, 6, Mittenberg, W., Rotholc, A., Russell, E., & Heilbronner, R. (1996). Identification of malingered head injury on the Halstead Reitan Battery. Archives of Clinical Neuropsychology, 11, Pankratz, L., & Binder, L. M. (1997). Malingering on intellectual and neuropsychological measures. In R. Rogers (Ed.), Clinical assessment of malingering and deception (2nd ed., pp ). New York: Guilford Press. Petersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L., & DeKosky, S. T. (2001). Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review). Report of the quality standards subcommittee of the American Academy of Neurology. Neurology, 56, Rees, L. M., Tombaugh, T. N., Gansler, D. A., & Moczynski, N. P. (1998). Five validation experiments of the Test of Memory Malinger (TOMM). Psychological Assessment, 10, Reitan, R. M., & Wolfson, D. (1998). Detection of malingering and invalid test results using the Halstead Reitan Battery. In C. R. Reynolds (Ed.), Detection of malingering during head injury litigation. Critical issues in neuropsychology (pp ). New York: Plenum Press. Scott-Killgore, W. D., & DellaPietra, L. (2000). Using the WMS-III to detect malingering: Empirical validation of the Rarely Missed Index (RMI). Journal of Clinical and Experimental Neuropsychology, 22, Slick, D. J., Sherman, E. M., & Iverson, G. L. (1999). Diagnostic criteria for malingered neurocognitive dysfunction: Proposed standards for clinical practice and research. Clinical Neuropsychologist, 13, Tombaugh, T. N. (1996). Test of Memory Malingering (TOMM). New York: Multi-Health Systems, Inc. Tombaugh, T. N. (1997). The Test of Memory Malingering (TOMM): Normative data from cognitively intact and cognitively impaired individuals. Psychological Assessment, 9, Wechsler, D. (1997). Wechsler adult intelligence scale Third edition: Administration and scoring manual. San Antonio, TX: The Psychological Corporation. Williams, J. M. (1998). The malingering of memory disorder. In C. R. Reynolds (Ed.), Detection of malingering during head injury litigation. Critical issues in neuropsychology (pp ). New York: Plenum Press.
Performance profiles and cut-off scores on the Memory Assessment Scales
Archives of Clinical Neuropsychology 19 (2004) 489 496 Performance profiles and cut-off scores on the Memory Assessment Scales Sid E. O Bryant a, Kevin Duff b, Jerid Fisher c, Robert J. McCaffrey a,d,
More informationThe Albany Consistency Index for the Test of Memory Malingering
Archives of Clinical Neuropsychology 27 (2012) 1 9 The Albany Consistency Index for the Test of Memory Malingering Jessica H. Gunner 1, *, Andrea S. Miele 1, Julie K. Lynch 2, Robert J. McCaffrey 1,2 1
More informationEffects of severe depression on TOMM performance among disability-seeking outpatients
Archives of Clinical Neuropsychology 21 (2006) 161 165 Effects of severe depression on TOMM performance among disability-seeking outpatients Y. Tami Yanez, William Fremouw, Jennifer Tennant, Julia Strunk,
More informationWPE. WebPsychEmpiricist
McKinzey, R. K., Podd, M., & Kreibehl, M. A. (6/25/04). Concurrent validity of the TOMM and LNNB. WebPsychEmpiricist. Retrieved (date), from http://wpe.info/papers_table.html WPE WebPsychEmpiricist Concurrent
More informationChapter 23. Detection of Children s Malingering on Raven s Standard Progressive Matrices*
Chapter 23 Detection of Children s Malingering on Raven s Standard Progressive Matrices* R. Kim McKinzey, Jörg Prieler, and John Raven** Abstract A formula for detecting faked Raven s Standard Progressive
More informationHead injury and the ability to feign neuropsychological deficits
Archives of Clinical Neuropsychology 19 (2004) 37 48 Head injury and the ability to feign neuropsychological deficits Chad D. Vickery, David T.R. Berry, Chantel S. Dearth, Victoria L. Vagnini, Raymond
More informationThe Repeatable Battery for the Assessment of Neuropsychological Status Effort Scale
Archives of Clinical Neuropsychology 27 (2012) 190 195 The Repeatable Battery for the Assessment of Neuropsychological Status Effort Scale Julia Novitski 1,2, Shelly Steele 2, Stella Karantzoulis 3, Christopher
More informationConcurrent validity of WAIS-III short forms in a geriatric sample with suspected dementia: Verbal, performance and full scale IQ scores
Archives of Clinical Neuropsychology 20 (2005) 1043 1051 Concurrent validity of WAIS-III short forms in a geriatric sample with suspected dementia: Verbal, performance and full scale IQ scores Brian L.
More informationSimulated subaverage performance on the Block Span task of the Stanford-Binet Intelligence Scales- Fifth Edition
Louisiana State University LSU Digital Commons LSU Master's Theses Graduate School 2011 Simulated subaverage performance on the Block Span task of the Stanford-Binet Intelligence Scales- Fifth Edition
More informationMinimizing Misdiagnosis: Psychometric Criteria for Possible or Probable Memory Impairment
Original Research Article DOI: 10.1159/000215390 Accepted: January 30, 2009 Published online: April 28, 2009 Minimizing Misdiagnosis: Psychometric Criteria for Possible or Probable Memory Impairment Brian
More informationRapidly-administered short forms of the Wechsler Adult Intelligence Scale 3rd edition
Archives of Clinical Neuropsychology 22 (2007) 917 924 Abstract Rapidly-administered short forms of the Wechsler Adult Intelligence Scale 3rd edition Alison J. Donnell a, Neil Pliskin a, James Holdnack
More informationORIGINAL CONTRIBUTION. Comparison of the Short Test of Mental Status and the Mini-Mental State Examination in Mild Cognitive Impairment
ORIGINAL CONTRIBUTION Comparison of the Short Test of Mental Status and the Mini-Mental State Examination in Mild Cognitive Impairment David F. Tang-Wai, MDCM; David S. Knopman, MD; Yonas E. Geda, MD;
More informationEcological Validity of the WMS-III Rarely Missed Index in Personal Injury Litigation. Rael T. Lange. Riverview Hospital.
This is the authors version of a paper that will be published as: Lange, Rael T. Lange and Sullivan, Karen A. and Anderson, Debbie (2005) Ecological validity of the WMS-III Rarely Missed Index in personal
More informationComparison of Predicted-difference, Simple-difference, and Premorbid-estimation methodologies for evaluating IQ and memory score discrepancies
Archives of Clinical Neuropsychology 19 (2004) 363 374 Comparison of Predicted-difference, Simple-difference, and Premorbid-estimation methodologies for evaluating IQ and memory score discrepancies Reid
More informationImproving the Methodology for Assessing Mild Cognitive Impairment Across the Lifespan
Improving the Methodology for Assessing Mild Cognitive Impairment Across the Lifespan Grant L. Iverson, Ph.D, Professor Department of Physical Medicine and Rehabilitation Harvard Medical School & Red Sox
More informationCharacterization of the Medical Symptom Validity Test in evaluation of clinically referred memory disorders clinic patients
Archives of Clinical Neuropsychology 22 (2007) 753 761 Characterization of the Medical Symptom Validity Test in evaluation of clinically referred memory disorders clinic patients Abstract Laura L.S. Howe
More informationThe unexamined lie is a lie worth fibbing Neuropsychological malingering and the Word Memory Test
Archives of Clinical Neuropsychology 17 (2002) 709 714 The unexamined lie is a lie worth fibbing Neuropsychological malingering and the Word Memory Test David E. Hartman Private Practice/Chicago Medical
More informationEffects of Coaching on Detecting Feigned Cognitive Impairment with the Category Test
Archives of Clinical Neuropsychology, Vol. 15, No. 5, pp. 399 413, 2000 Copyright 2000 National Academy of Neuropsychology Printed in the USA. All rights reserved 0887-6177/00 $ see front matter PII S0887-6177(99)00031-1
More informationCriterion validity of the California Verbal Learning Test-Second Edition (CVLT-II) after traumatic brain injury
Archives of Clinical Neuropsychology 22 (2007) 143 149 Criterion validity of the California Verbal Learning Test-Second Edition (CVLT-II) after traumatic brain injury Monica L. Jacobs, Jacobus Donders
More informationInterpreting change on the WAIS-III/WMS-III in clinical samples
Archives of Clinical Neuropsychology 16 (2001) 183±191 Interpreting change on the WAIS-III/WMS-III in clinical samples Grant L. Iverson* Department of Psychiatry, University of British Columbia, 2255 Wesbrook
More informationMalingering (AADEP Position Paper) The gross volitional exaggeration or fabrication of symptoms/dysfunction for the purpose of obtaining substantial m
Malingering in Pain Management Gerald M. Aronoff, M.D. Medical Director, Carolina Pain Associates, Charlotte, NC, USA General Principles Treating physician vs IME physician Subjective history is not fact
More informationHealthy Children Get Low Scores Too: Prevalence of Low Scores on the NEPSY-II in Preschoolers, Children, and Adolescents
Archives of Clinical Neuropsychology 25 (2010) 182 190 Healthy Children Get Low Scores Too: Prevalence of Low Scores on the NEPSY-II in Preschoolers, Children, and Adolescents Brian L. Brooks 1, *, Elisabeth
More informationClinical Utility of Wechsler Memory Scale-Revised and Predicted IQ Discrepancies in Closed Head Injury
@ Pergamon Archives of Clinical Neuropsychology, Vol. 12, No. 8, pp. 757 762, 1997 Copyright 1997 Nationaf Academy ofneuropsychology Printed inthe USA, All rights reserved 0887-6177/97$17.00+.00 PIIS0887-6177(97)OO049-8
More informationBase Rates of Impaired Neuropsychological Test Performance Among Healthy Older Adults
Archives of Clinical Neuropsychology, Vol. 13, No. 6, pp. 503 511, 1998 Copyright 1998 National Academy of Neuropsychology Printed in the USA. All rights reserved 0887-6177/98 $19.00.00 PII S0887-6177(97)00037-1
More informationExaggerated MMPI-2 symptom report in personal injury litigants with malingered neurocognitive deficit
Archives of Clinical Neuropsychology 18 (2003) 673 686 Exaggerated MMPI-2 symptom report in personal injury litigants with malingered neurocognitive deficit Glenn J. Larrabee Suite 202, 630 South Orange
More informationDonald A. Davidoff, Ph.D., ABPDC Chief, Neuropsychology Department, McLean Hospital Assistant Professor of Psychology, Harvard Medical School
Donald A. Davidoff, Ph.D., ABPDC Chief, Neuropsychology Department, McLean Hospital Assistant Professor of Psychology, Harvard Medical School Interests: Adult/Geriatric/Forensic Neuropsychology ddavidoff@mclean.harvard.edu
More informationPotential for interpretation disparities of Halstead Reitan neuropsychological battery performances in a litigating sample,
Archives of Clinical Neuropsychology 21 (2006) 809 817 Potential for interpretation disparities of Halstead Reitan neuropsychological battery performances in a litigating sample, Abstract Christine L.
More informationDiscriminant Function Analysis of Malingerers and Neurological Headache Patients Self- Reports of Neuropsychological Symptoms
Archives of Clinical Neuropsychology, Vol. 13, No. 6, pp. 561 567, 1998 Copyright 1998 National Academy of Neuropsychology Printed in the USA. All rights reserved 0887-6177/98 $19.00.00 PII S0887-6177(97)00072-3
More informationUtility of a clinically derived abbreviated form of the WAIS-III
Archives of Clinical Neuropsychology 18 (2003) 917 927 Utility of a clinically derived abbreviated form of the WAIS-III Joy H. Wymer, Katrina Rayls 1, Mark T. Wagner 2 Psychological Assessment Center,
More informationClinical Study Depressive Symptom Clusters and Neuropsychological Performance in Mild Alzheimer s and Cognitively Normal Elderly
Hindawi Publishing Corporation Depression Research and Treatment Volume 2011, Article ID 396958, 6 pages doi:10.1155/2011/396958 Clinical Study Depressive Symptom Clusters and Neuropsychological Performance
More informationYour choice of SVTs is fundamental to the Slick et al criteria Paul Green Ph.D. paulgreen@shaw.ca www.wordmemorytest.com Central to the criteria is the presence of cognitive symptom exaggeration or feigning
More informationI n the past three decades various cognitive screening
700 PAPER The seven minute screen: a neurocognitive screening test highly sensitive to various types of dementia E F J Meulen, B Schmand, J P van Campen, S J de Koning, R W Ponds, P Scheltens, F R Verhey...
More informationElderly Norms for the Hopkins Verbal Learning Test-Revised*
The Clinical Neuropsychologist -//-$., Vol., No., pp. - Swets & Zeitlinger Elderly Norms for the Hopkins Verbal Learning Test-Revised* Rodney D. Vanderploeg, John A. Schinka, Tatyana Jones, Brent J. Small,
More informationComparison of Performance of the Test of Memory Malingering and Word Memory Test in a Criminal Forensic Sample
Archives of Clinical Neuropsychology Advance Access published May 5, 2015 Comparison of Performance of the Test of Memory Malingering and Word Memory Test in a Criminal Forensic Sample Rachel L. Fazio
More informationTest Assessment Description Ref. Global Deterioration Rating Scale Dementia severity Rating scale of dementia stages (2) (4) delayed recognition
Table S. Cognitive tests used in the Georgia Centenarian Study. Test Assessment Description Ref. Mini-Mental State Examination Global cognitive performance A brief screening of orientation, memory, executive
More informationCognitive Screening in Risk Assessment. Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University.
Cognitive Screening in Risk Assessment Geoffrey Tremont, Ph.D. Rhode Island Hospital & Alpert Medical School of Brown University Outline of Talk Definition of Dementia and MCI Incidence and Prevalence
More informationNeuropsychological Testing (NPT)
Neuropsychological Testing (NPT) POLICY Psychological testing (96101-03) refers to a series of tests used to evaluate and treat an individual with emotional, psychiatric, neuropsychiatric, personality
More informationInterpretive Report. Client Information
Interpretive Report Developed by Michelle R. Widows, PhD, Glenn P. Smith, PhD, and PAR Staff Client Information Client name: Sample Client Client ID: SIMS Test date: 08/12/2013 Date of birth: 02/03/1975
More informationFactors Influencing the Face Validity of Effort Tests: Timing of Warning and Feedback
University of Montana ScholarWorks at University of Montana Graduate Student Theses, Dissertations, & Professional Papers Graduate School 2 Factors Influencing the Face Validity of Effort Tests: Timing
More informationRecognizing Dementia can be Tricky
Dementia Abstract Recognizing Dementia can be Tricky Dementia is characterized by multiple cognitive impairments that cause significant functional decline. Based on this brief definition, the initial expectation
More informationEmpire BlueCross BlueShield Professional Commercial Reimbursement Policy
Subject: Documentation Guidelines for Central Nervous System Assessments and Tests NY Policy: 0046 Effective: 12/01/2014 11/30/2015 Coverage is subject to the terms, conditions, and limitations of an individual
More informationInformation/Orientation Subtest of the Wechsler Memory Scale-Revised as an Indicator of Suspicion of Insufficient Effort*
The Clinical Neuropsychologist 1385-4046/00/1401-056$15.00 2000, Vol. 14, No. 1, pp. 56-66 Swets & Zeitlinger Information/Orientation Subtest of the Wechsler Memory Scale-Revised as an Indicator of Suspicion
More informationCarolyn M. Sherer, M.A.
Carolyn M. Sherer, M.A. CarolynMSherer@gmail.com Education: University of Indianapolis, Indianapolis, IN Fully Accredited by the American Psychological Association Doctoral Student in Clinical Psychology
More informationEARLY ONSET FRONTOTERMPORAL DEMENTIA AND ALZHEIMERS DISEASE: DIAGNOSIS, TREATMENT AND CARE
EARLY ONSET FRONTOTERMPORAL DEMENTIA AND ALZHEIMERS DISEASE: DIAGNOSIS, TREATMENT AND CARE John Rudge, BA Hons This thesis is presented as partial requirement for the degree of Doctor of Psychology at
More informationVALIDATION OF THE MILLER FORENSIC ASSESSMENT OF SYMPTOMS TEST (M- FAST) IN A CIVIL FORENSIC POPULATION
University of Kentucky UKnowledge University of Kentucky Master's Theses Graduate School 2006 VALIDATION OF THE MILLER FORENSIC ASSESSMENT OF SYMPTOMS TEST (M- FAST) IN A CIVIL FORENSIC POPULATION Jessica
More informationDetection and diagnosis of malingering in electrical injury
Archives of Clinical Neuropsychology 20 (2005) 365 373 Detection and diagnosis of malingering in electrical injury Kevin Bianchini a,b, Jeffrey M. Love a,1, Kevin W. Greve a,b,, Donald Adams c Abstract
More informationTrail making test A 2,3. Memory Logical memory Story A delayed recall 4,5. Rey auditory verbal learning test (RAVLT) 2,6
NEUROLOGY/2016/790584 Table e-1: Neuropsychological test battery Cognitive domain Test Attention/processing speed Digit symbol-coding 1 Trail making test A 2,3 Memory Logical memory Story A delayed recall
More informationUse of the Kaufman Brief Intelligence Test - Second Edition as an embedded measure of malingering in a college population
Fort Hays State University FHSU Scholars Repository Master's Theses Graduate School Spring 2010 Use of the Kaufman Brief Intelligence Test - Second Edition as an embedded measure of malingering in a college
More informationNeuropsychological Evaluation of
Neuropsychological Evaluation of Alzheimer s Disease Joanne M. Hamilton, Ph.D. Shiley-Marcos Alzheimer s Disease Research Center Department of Neurosciences University of California, San Diego Establish
More informationArchives of Clinical Neuropsychology 31 (2016)
Archives of Clinical Neuropsychology 31 (2016) 313 331 False-Positive Error Rates for Reliable Digit Span and Auditory Verbal Learning Test Performance Validity Measures in Amnestic Mild Cognitive Impairment
More informationInternational Journal of Forensic Psychology Copyright Volume 1, No. 3 SEPTEMBER 2006 pp. 1-21
International Journal of Forensic Psychology Copyright 2006 Volume 1, o. 3 SEPTEMBER 2006 pp. 1-21 The Pervasive Influence of Effort on europsychological Tests Paul Green + eurobehavioural Associates,
More informationCHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE
CHAPTER 5 NEUROPSYCHOLOGICAL PROFILE OF ALZHEIMER S DISEASE 5.1 GENERAL BACKGROUND Neuropsychological assessment plays a crucial role in the assessment of cognitive decline in older age. In India, there
More informationAn empirical analysis of the BASC Frontal Lobe/Executive Control scale with a clinical sample
Archives of Clinical Neuropsychology 21 (2006) 495 501 Abstract An empirical analysis of the BASC Frontal Lobe/Executive Control scale with a clinical sample Jeremy R. Sullivan a,, Cynthia A. Riccio b
More informationEffortless Effort: Current Views on Assessing Malingering litigants in Neuropsychological Assessments
Article ID: WMC002014 2046-1690 Effortless Effort: Current Views on Assessing Malingering litigants in Neuropsychological Assessments Corresponding Author: Dr. Simon B Thompson, Associate Professor, Psychology
More informationAPPLYING REACTION TIME (RT) AND EVENT-RELATED POTENTIAL (ERPS) MEASURES TO DETECT MALINGERED NEUROCOGNITIVE DEFICIT
University of Kentucky UKnowledge University of Kentucky Doctoral Dissertations Graduate School 2007 APPLYING REACTION TIME (RT) AND EVENT-RELATED POTENTIAL (ERPS) MEASURES TO DETECT MALINGERED NEUROCOGNITIVE
More informationTHE EFFICIACY OF THE MMPI-2 LEES- HALEY FAKE BAD SCALE (FBS) FOR DIFFERENTIATING NEUROCOGNITIVE AND PSYCHIATRIC FEIGNERS
University of Kentucky UKnowledge University of Kentucky Doctoral Dissertations Graduate School 2003 THE EFFICIACY OF THE MMPI-2 LEES- HALEY FAKE BAD SCALE (FBS) FOR DIFFERENTIATING NEUROCOGNITIVE AND
More informationPublished online: 12 Dec 2014.
This article was downloaded by: [52.1.27.110] On: 26 August 2015, At: 23:28 Publisher: Routledge Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered office: 5 Howick Place,
More informationBaseline Characteristics of Patients Attending the Memory Clinic Serving the South Shore of Boston
Article ID: ISSN 2046-1690 Baseline Characteristics of Patients Attending the www.thealzcenter.org Memory Clinic Serving the South Shore of Boston Corresponding Author: Dr. Anil K Nair, Chief of Neurology,
More informationQualitative scoring of the Rey 15-Item Memory Test in a forensic population
Louisiana State University LSU Digital Commons LSU Doctoral Dissertations Graduate School 2002 Qualitative scoring of the Rey 15-Item Memory Test in a forensic population James A. Martin Louisiana State
More informationUse a diagnostic neuropsychology HOW TO DO IT PRACTICAL NEUROLOGY
170 PRACTICAL NEUROLOGY HOW TO DO IT Pract Neurol: first published as 10.1046/j.1474-7766.2003.08148.x on 1 June 2003. Downloaded from http://pn.bmj.com/ Use a diagnostic neuropsychology on 16 October
More informationThe Delis-Kaplan Executive Functions System Tower Test Resilience to Response Bias
Ursidae: The Undergraduate Research Journal at the University of Northern Colorado Volume 1 Number 2 Article 2 January 2012 The Delis-Kaplan Executive Functions System Tower Test Resilience to Response
More informationUsing Neuropsychological Experts. Elizabeth L. Leonard, PhD
Using Neuropsychological Experts Elizabeth L. Leonard, PhD Prepared for Advocate. Arizona Association for Justice/Arizona Trial Lawyers Association. September, 2011 Neurocognitive Associates 9813 North
More informationBackground 6/24/2014. Validity Testing in Pediatric Populations. Michael Kirkwood, PhD, ABPP/CN. Conflict of Interest Statement
Validity Testing in Pediatric Populations Michael Kirkwood, PhD, ABPP/CN Background Board Certified Clinical Neuropsychologist at Children s Hospital Colorado Exclusively pediatric-focused Patient work
More informationProcess of a neuropsychological assessment
Test selection Process of a neuropsychological assessment Gather information Review of information provided by referrer and if possible review of medical records Interview with client and his/her relative
More informationNACC Minimum Data Set (MDS) Public Data Element Dictionary
Department of Epidemiology, School of Public Health and Community Medicine, University of Washington 4311 11 th Avenue NE #300 Seattle, WA 98105 phone: (206) 543-8637; fax: (206) 616-5927 e-mail: naccmail@u.washington.edu
More informationPRELIMINARY NORMS FOR YEAR OLDS ON THE MEMORY TEST FOR OLDER ADULTS (MTOA:S) ABSTRACT
The University of British Columbia PRELIMINARY NORMS FOR 85-99 YEAR OLDS ON THE MEMORY TEST FOR OLDER ADULTS (MTOA:S) Anita M. Hubley University of British Columbia Vancouver, BC, Canada Poster presented
More informationOverview. Case #1 4/20/2012. Neuropsychological assessment of older adults: what, when and why?
Neuropsychological assessment of older adults: what, when and why? Benjamin Mast, Ph.D. Associate Professor & Vice Chair, Psychological & Brain Sciences Associate Clinical Professor, Family & Geriatric
More information(Received 30 March 1990)
Person, individ. Diff. Vol. II, No. 11, pp. 1153-1157, 1990 0191-8869/90 $3.00 + 0.00 Printed in Great Britain. All rights reserved Copyright 1990 Pergamon Press pic ESTIMATING PREMORBID INTELLIGENCE BY
More informationSupplementary Online Content
Supplementary Online Content Sun LS, Li G, Miller TLK, et al. Association between a single general anesthesia exposure before age 36 months and neurocognitive outcomes in later childhood. JAMA. doi:10.1001/jama.2016.6967
More information10/5/2015. Advances in Pediatric Neuropsychology Test Interpretation Part I: Importance of Considering Normal Variability. Financial Disclosures
Advances in Pediatric Neuropsychology Test Interpretation: Importance of Considering Normal Variability and Performance Variability Brian L. Brooks, PhD Alberta Children s Hospital University of Calgary
More informationOriginal Articles. Calne, resting tremor. Mortimer, Pirozzolo, Hansch, & Webster, postural disturbance III
2004 97-106 Original Articles 1 2 3 1 1 2 3 47 22 III I II muscular rigidity postural disturbance resting tremor bradykinesia Calne, 2001 Mortimer, Pirozzolo, Hansch, & Webster, 1982 Tel: 02-23627076 E-mail:
More informationTest-retest reliable coefficients and 5-year change scores for the MMSE and 3MS
Archives of Clinical Neuropsychology 20 (2005) 485 503 Test-retest reliable coefficients and 5-year change scores for the MMSE and 3MS Tom N. Tombaugh Psychology Department, Carleton University, 1125 Colonel
More informationDETECTION OF MALINGERED MENTAL RETARDATION
University of Kentucky UKnowledge University of Kentucky Master's Theses Graduate School 2006 DETECTION OF MALINGERED MENTAL RETARDATION Lili Odom Graue University of Kentucky, lili.graue@uky.edu Click
More informationAn Initial Validation of Virtual Human Administered Neuropsychological Assessments
Annual Review of Cybertherapy and Telemedicine 2017 123 An Initial Validation of Virtual Human Administered Neuropsychological Assessments Thomas D. PARSONS a,*, Paul SCHERMERHORN b, Timothy MCMAHAN a,
More informationDOES IMPAIRED EXECUTIVE FUNCTIONING DIFFERENTIALLY IMPACT VERBAL MEMORY MEASURES IN OLDER ADULTS WITH SUSPECTED DEMENTIA?
The Clinical Neuropsychologist, 20: 230 242, 2006 Copyright # Taylor and Francis Group, LLC ISSN: 1385-4046 print=1744-4144 online DOI: 10.1080/13854040590947461 DOES IMPAIRED EXECUTIVE FUNCTIONING DIFFERENTIALLY
More informationCarmen Inoa Vazquez, Ph.D., ABPP Clinical Professor NYU School of Medicine Lead Litigation Conference Philadelphia May 19, 2009 Presentation
Carmen Inoa Vazquez, Ph.D., ABPP Clinical Professor NYU School of Medicine Lead Litigation Conference Philadelphia May 19, 2009 Presentation Neuropsychological Tests Battery The following List represents
More informationWhat s Wrong With My Client: Understanding Psychological Testing in Order to Work Effectively With Your Expert
What s Wrong With My Client: Understanding Psychological Testing in Order to Work Effectively With Your Expert Common Standardized, Norm Referenced Psychological Tests: Diagnostic ( Personality ) Tests:
More informationPreliminary examination of cognitive reserve theory in closed head injury
Archives of Clinical Neuropsychology 18 (2003) 643 654 Abstract Preliminary examination of cognitive reserve theory in closed head injury Michael T. Ropacki a,, Jeffrey W. Elias b a University of Oklahoma
More informationCLINICAL NEUROPSYCHOLOGY PSYC32
University of Toronto at Scarborough Department of Psychology CLINICAL NEUROPSYCHOLOGY PSYC32 Ψ Course Instructor: Zakzanis Lab Instructor: Konstantine Eliyas Jeffay Course Code: PSYC32H3 Lecture: Tuesdays,
More informationGeriatric performance on the Neurobehavioral Cognitive Status Examination (Cognistat) What is normal?
Archives of Clinical Neuropsychology 18 (2003) 463 471 Geriatric performance on the Neurobehavioral Cognitive Status Examination (Cognistat) What is normal? Abstract Caitlin Macaulay a,, Matthew Battista
More informationEstimating the Validity of the Korean Version of Expanded Clinical Dementia Rating (CDR) Scale
Estimating the Validity of the Korean Version of Expanded Clinical Dementia Rating (CDR) Scale Seong Hye Choi, M.D.*, Duk L. Na, M.D., Byung Hwa Lee, M.A., Dong-Seog Hahm, M.D., Jee Hyang Jeong, M.D.,
More informationMedical Symptom Validity Test Performance Following Moderate-Severe Traumatic Brain Injury: Expectations Based on Orientation Log Classification
Archives of Clinical Neuropsychology 32 (2017) 339 348 Medical Symptom Validity Test Performance Following Moderate-Severe Traumatic Brain Injury: Expectations Based on Orientation Log Classification Abstract
More informationA Multi-Method Assessment Approach to the Detection of Malingered Pain: Association with the MMPI-2 Restructured Form
Eastern Kentucky University Encompass Online Theses and Dissertations Student Scholarship 2011 A Multi-Method Assessment Approach to the Detection of Malingered Pain: Association with the MMPI-2 Restructured
More informationComments to this discussion are invited on the Alzforum Webinar page. Who Should Use the New Diagnostic Guidelines? The Debate Continues
Comments to this discussion are invited on the Alzforum Webinar page. Who Should Use the New Diagnostic s? The Debate Continues Ever since new criteria came out for a research diagnosis of prodromal/preclinical
More informationORIGINAL ARTICLE Neuroscience INTRODUCTION MATERIALS AND METHODS
ORIGINAL ARTICLE Neuroscience DOI: 10.46/jkms.2010.25.7.1071 J Korean Med Sci 2010; 25: 1071-1076 Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): A Useful Tool for Assessing and Monitoring
More informationMalingering in the Primary Care Setting. Jeremy Di Bari, DVM, MD M elissa Arthur, PhD
Malingering in the Primary Care Setting Jeremy Di Bari, DVM, MD M elissa Arthur, PhD Simulation of Illness Both malingering and factitious disorder involve simulating an illness Malingering Illness falsification
More informationKEVIN J. BIANCHINI, PH.D., ABPN
KEVIN J. BIANCHINI, PH.D., ABPN Slick et al., 1999 Bianchini et al., 2005 4 4 Criterion A: Evidence of significant external incentive Criterion B: Evidence from physical evaluation 1. Probable effort
More informationAN ESTABLISHMENT OF EMBEDDED SYMPTOM VALIDITY TESTING WITHIN THE DELIS-KAPLAN EXECUTIVE FUNCTIONING SYSTEM. A Dissertation by. Emanuel J.
AN ESTABLISHMENT OF EMBEDDED SYMPTOM VALIDITY TESTING WITHIN THE DELIS-KAPLAN EXECUTIVE FUNCTIONING SYSTEM A Dissertation by Emanuel J. VonDran Master of Arts, Wichita State University, 2011 Bachelor of
More informationMild cognitive impairment (MCI) is an intermediate
BRIEF METHODOLOGICAL REPORTS The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment Ziad S. Nasreddine, MD, wz Natalie A. Phillips, PhD, z z Valérie Bédirian, BSc,
More informationDepartment of Psychology, Sungkyunkwan University, Seoul, Korea
Print ISSN 1738-1495 / On-line ISSN 2384-0757 Dement Neurocogn Disord 2015;14(4):137-142 / http://dx.doi.org/10.12779/dnd.2015.14.4.137 ORIGINAL ARTICLE DND Constructing a Composite Score for the Seoul
More informationTable 7.2B: Summary of Select Screening Tools for Assessment of Vascular Cognitive Impairment in Stroke Patients
Table 7.2B: Summary of Select Screening Tools for Assessment of Vascular Cognitive Impairment in Stroke Patients Recommended First Line Screening and s Montreal Cognitive (MoCA) The MoCA is available for
More informationA semantic verbal fluency test for English- and Spanish-speaking older Mexican-Americans
Archives of Clinical Neuropsychology 20 (2005) 199 208 A semantic verbal fluency test for English- and Spanish-speaking older Mexican-Americans Hector M. González a,, Dan Mungas b, Mary N. Haan a a University
More informationThe Reliability and Validity of the Korean Instrumental Activities of Daily Living (K-IADL)
The Reliability and Validity of the Korean Instrumental Activities of Daily Living (K-IADL Sue J. Kang, M.S., Seong Hye Choi, M.D.*, Byung H. Lee, M.A., Jay C. Kwon, M.D., Duk L. Na, M.D., Seol-Heui Han
More informationTHE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME
PERNECZKY 15/06/06 14:35 Page 1 THE ROLE OF ACTIVITIES OF DAILY LIVING IN THE MCI SYNDROME R. PERNECZKY, A. KURZ Department of Psychiatry and Psychotherapy, Technical University of Munich, Germany. Correspondence
More informationNeuropsychological detection and characterization of preclinical Alzheimer s disease
Neuropsychological detection and characterization of preclinical Alzheimer s disease D.M. Jacobs, PhD; M. Sano, PhD; G. Dooneief, MD; K. Marder, MD; K.L. Bell, MD; and Y. Stern, PhD Article abstract-we
More informationRonette Goodwin, Ph.D. Forensic and Psychological Experts, Inc Crenshaw Blvd. #179 Torrance, CA (866)
Ronette Goodwin, Ph.D. Forensic and Psychological Experts, Inc. 2390 Crenshaw Blvd. #179 Torrance, CA. 90501 (866) 853-0056 goodwindoc@aol.com ACADEMIC BACKGROUND August 2001 Harbor UCLA Medical Center,
More informationForm A3: Subject Family History
Initial Visit Packet NACC Uniform Data Set (UDS) Form A: Subject Family History ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to be completed by a clinician
More informationThe current state of healthcare for Normal Aging, Mild Cognitive Impairment, & Alzheimer s Disease
The current state of healthcare for Normal Aging, g, Mild Cognitive Impairment, & Alzheimer s Disease William Rodman Shankle, MS MD FACP Director, Alzheimer s Program, Hoag Neurosciences Institute Neurologist,
More informationErin Cullnan Research Assistant, University of Illinois at Chicago
Dr. Moises Gaviria Distinguished Professor of Psychiatry, University of Illinois at Chicago Director of Consultation Liaison Service, Advocate Christ Medical Center Director of the Older Adult Program,
More informationSOCIABLE - NEXT GENERATION COGNITIVE TRAINING USING MULTI-TOUCH SURFACE COMPUTERS
SOCIABLE - NEXT GENERATION COGNITIVE TRAINING USING MULTI-TOUCH SURFACE COMPUTERS Dr Paraskevi Sakka Neurologist - Psychiatrist Athens Association of Alzheimer s Disease and Related Disorders Neurodegenerative
More information